In 2017, according to the Centers for Disease Control and Prevention (CDC), 1.3 million Americans went to the emergency room and were diagnosed with pneumonia—an infection where air sacs in the lungs become filled with infected fluid. Unfortunately, pneumonia not only increases your COVID-19 risk profile, but it has also become a serious complication for some who have already tested positive for COVID-19. So let’s break it down.

It’s been a long journey since we first found cases of COVID-19 in the United States. But those in the medical field have worked tirelessly from the beginning to research the virus to develop both vaccines and safe treatment options. Now, one of the safest and most effective treatment options available to high-risk COVID-positive patients—monoclonal antibody therapy—is more accessible than ever. However, recent reporting shows that many providers just don’t know where monoclonal antibody treatments are available, let alone how to enroll their patients in treatment.

Inspira Medical Center Vineland, part of Inspira Health, is now using Auris Health’s Monarch™ Platform to peer inside patients’ lungs and obtain tissue samples for biopsy.